Bharat Immunologicals and Biologicals Corporation Q1FY22 net profit at Rs. 1.92 Cr

The company reported total income Rs.18.57 crores during the period ended June 30, 2020.

Govt. to procure 30 Cr COVID-19 vaccine doses from Biological-E

These vaccine doses will be manufactured and stockpiled by the company from August-December 2021

Crown Bioscience partners with Turbine to accelerate translational oncology research

The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems

New guardian protein mechanism identified in aggressive skin cancer progression

While many cases are treatable, a subset can become highly aggressive, spreading to distant organs and resisting conventional therapies

India–UK life sciences research to advance through new cross-border innovation corridor

C-CAMP–Imperial College London partnership to boost biotech research, startup exchange, and translational innovation through a five-year collaboration

NADMED forms global Scientific Advisory Board to advance redox diagnostics and precision medicine

The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways

MicrobioTx launches IBS Risk Score to enable early detection of gut disorder

The launch coincides with IBS Awareness Month in April

NIT Rourkela develops novel bio-ink for 3D bioprinting and tissue engineering

The innovation is particularly suited for bone and cartilage repair

AWS unveils Amazon Bio Discovery to accelerate drug design with AI

AIG Hospitals Chairman Dr D. Nageshwar Reddy elected to elite AIMBE College of Fellows

Among his notable contributions is the development of the NAGI Stent, a widely adopted device for the drainage of pancreatic pseudocysts